{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:42:43Z","timestamp":1767339763074},"reference-count":20,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1507\/endocrj.ej17-0487","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T22:24:27Z","timestamp":1533335067000},"page":"1061-1067","source":"Crossref","is-referenced-by-count":9,"title":["Impact of preoperative pasireotide therapy on invasive octreotide-resistant acromegaly"],"prefix":"10.1507","volume":"65","author":[{"given":"Reina","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Robert Shima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirobumi","family":"Igawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Kaikoi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Sasagawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Inoshita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Tokyo 105-8470, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinari","family":"Takamura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Giustina A, Chanson P, Kleinberg D, Bronstein MD, Clemons DR, et al. (2014) Expert consensus document: a consensus on the medical treatment of acromegaly. Nat Rev Endocrinol 10: 243\u2013248.","DOI":"10.1038\/nrendo.2014.21"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Donoho DA, Bose N, Zada G, Carmichael JD (2017) Management of aggressive growth hormone secreting pituitary adenomas. Pituitary 20: 169\u2013178.","DOI":"10.1007\/s11102-016-0781-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen \u00d8, et al. (2008) Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J Clin Endocrinol Metab 93: 2984\u20132990.","DOI":"10.1210\/jc.2008-0315"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Mayr B, Buslei R, Theodoropoulou M, Stalla GK, Buchfelder M, et al. (2013) Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas. Eur J Endocrinol 169: 391\u2013400.","DOI":"10.1530\/EJE-13-0134"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Obari A, Sano T, Ohyama K, Kudo E, Qian ZR, et al. (2008) Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 19: 82\u201391.","DOI":"10.1007\/s12022-008-9029-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Volante M, Brizzi MP, Faggiano A, La Rosa S, Rapa I, et al. (2007) Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 20: 1172\u20131182.","DOI":"10.1038\/modpathol.3800954"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Matsumoto R, Izawa M, Fukuoka H, Iguchi G, Odake Y, et al. (2016) Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma. Endocr J 63: 953\u2013963.","DOI":"10.1507\/endocrj.EJ16-0075"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Colao A, Bronstein MD, Freda P, Gu F, Shen CC, et al. (2014) Pasireotide <i>versus<\/i> octreotide in acromegaly: a head-to-head superiority study. J Clin Endocrinol Metab 99: 791\u2013799.","DOI":"10.1210\/jc.2013-2480"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Chang JS, Tseng HM, Chang TC (2016) Serial follow-up of presurgical treatment using pasireotide long-acting release with or without octreotide long-acting release for na\u00efve active acromegaly. J Formos Med Assoc 115: 475\u2013480.","DOI":"10.1016\/j.jfma.2016.02.003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Gadelha MR, Kasuki L, Korbonits M (2013) Novel pathway for somatostatin analogs in patients with acromegaly. Trends Endocrinol Metab 24: 238\u2013246.","DOI":"10.1016\/j.tem.2012.11.007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Potorac I, Beckers A, Bonneville JF (2017) T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective. Pituitary 20: 116\u2013120.","DOI":"10.1007\/s11102-017-0788-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Bronstein MD, Fleseriu M, Neggers S, Colao A, Sheppard M, et al. (2016) Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, phase III study. BMC Endocr Disord 16: 16.","DOI":"10.1186\/s12902-016-0096-8"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13 Brzana J, Yedinak CG, Gultekin SH, Delashaw JB, Fleseriu M (2013) Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience. Pituitary 16: 490\u2013498.","DOI":"10.1007\/s11102-012-0445-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Iacovazzo D, Carlsen E, Lugli F, Chiloiro S, Piacentini S, et al. (2016) Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. Eur J Endocrinol 174: 241\u2013250.","DOI":"10.1530\/EJE-15-0832"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Bruns C, Lewis I, Briner U, Meno-Tetang G, Weckbecker G (2002) SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 146: 707\u2013716.","DOI":"10.1530\/eje.0.1460707"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kasuki L, Vieira Neto L, Wildemberg LEA, Colli LM, de Castro M, et al. (2012) AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression. Endocr Relat Cancer 19: L25\u2013L29.","DOI":"10.1530\/ERC-12-0020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 George SR, Kovacs K, Asa SL, Horvath E, Cross EG, et al. (1987) Effect of SMS 201\u2013995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma. Clin Endocrinol (Oxf) 26: 395\u2013405.","DOI":"10.1111\/j.1365-2265.1987.tb00796.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Gadelha MR, Bronstein MD, Brue T, Coculescu M, Fleseriu M, et al. (2014) Pasireotide <i>versus<\/i> continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial. Lancet Diabetes Endocrinol 2: 875\u2013884.","DOI":"10.1016\/S2213-8587(14)70169-X"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Henry RR, Ciaraldi TP, Armstrong D, Burke P, Ligueros-Saylan M, et al. (2013) Hyperglycemia associated with pasireotide: results from a mechanistic study in Healthy Volunteers. J Clin Endocrinol Metab 98: 3446\u20133453.","DOI":"10.1210\/jc.2013-1771"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Silverstein JM (2016) Hyperglycemia induced by pasireotide in patients with Cushing\u2019s disease or acromegaly. Pituitary 19: 536\u2013543.","DOI":"10.1007\/s11102-016-0734-1"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/10\/65_EJ17-0487\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T04:19:48Z","timestamp":1541218788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/10\/65_EJ17-0487\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej17-0487","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}